These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 24332649)

  • 21. Informed Decision Making: Assessment of the Quality of Physician Communication about Prostate Cancer Diagnosis and Treatment.
    Holmes-Rovner M; Montgomery JS; Rovner DR; Scherer LD; Whitfield J; Kahn VC; Merkle EC; Ubel PA; Fagerlin A
    Med Decis Making; 2015 Nov; 35(8):999-1009. PubMed ID: 26304063
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Who makes the decision regarding the treatment of clinically localized prostate cancer--the patient or physician?: results from a population-based study.
    Song L; Chen RC; Bensen JT; Knafl GJ; Nielsen ME; Farnan L; Wallen EM; Mishel M; Pruthi RS; Mohler JL; Godley PA
    Cancer; 2013 Jan; 119(2):421-8. PubMed ID: 22786794
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Decision Support and Shared Decision Making About Active Surveillance Versus Active Treatment Among Men Diagnosed with Low-Risk Prostate Cancer: a Pilot Study.
    Myers RE; Leader AE; Censits JH; Trabulsi EJ; Keith SW; Petrich AM; Quinn AM; Den RB; Hurwitz MD; Lallas CD; Hegarty SE; Dicker AP; Zeigler-Johnson CM; Giri VN; Ayaz H; Gomella LG
    J Cancer Educ; 2018 Feb; 33(1):180-185. PubMed ID: 27418065
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Shared decision making, physicians' explanations, and treatment satisfaction: a cross-sectional survey of prostate cancer patients.
    Nakayama K; Osaka W; Matsubara N; Takeuchi T; Toyoda M; Ohtake N; Uemura H
    BMC Med Inform Decis Mak; 2020 Dec; 20(1):334. PubMed ID: 33317523
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Active surveillance for low-risk localized prostate cancer: what do men and their partners think?
    Mallapareddi A; Ruterbusch J; Reamer E; Eggly S; Xu J
    Fam Pract; 2017 Feb; 34(1):90-97. PubMed ID: 28034917
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Elderly prostate cancer patients: patient information and shared decision making].
    Ernstmann N; Jaeger J; Kowalski C; Pfaff H; Weißbach L
    Urologe A; 2013 Jun; 52(6):847-52. PubMed ID: 23328778
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Physicians recommend different treatments for patients than they would choose for themselves.
    Ubel PA; Angott AM; Zikmund-Fisher BJ
    Arch Intern Med; 2011 Apr; 171(7):630-4. PubMed ID: 21482835
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Determinants of active surveillance uptake in a diverse population-based cohort of men with low-risk prostate cancer: The Treatment Options in Prostate Cancer Study (TOPCS).
    Xu J; Bock CH; Janisse J; Woo J; Cher ML; Ginsburg K; Yacoub R; Goodman M
    Cancer; 2024 May; 130(10):1797-1806. PubMed ID: 38247317
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment decision-making for localized prostate cancer: what younger men choose and why.
    Sidana A; Hernandez DJ; Feng Z; Partin AW; Trock BJ; Saha S; Epstein JI
    Prostate; 2012 Jan; 72(1):58-64. PubMed ID: 21520163
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Public Perceptions of Physician Attire and Professionalism in the US.
    Xun H; Chen J; Sun AH; Jenny HE; Liang F; Steinberg JP
    JAMA Netw Open; 2021 Jul; 4(7):e2117779. PubMed ID: 34328503
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The influence of physician recommendation on prostate-specific antigen screening.
    Pucheril D; Dalela D; Sammon J; Sood A; Sun M; Trinh QD; Menon M; Abdollah F
    Urol Oncol; 2015 Oct; 33(10):424.e1-7. PubMed ID: 26206103
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Factors influencing treatment decision making and information preferences of prostate cancer patients on active surveillance.
    Davison BJ; Breckon E
    Patient Educ Couns; 2012 Jun; 87(3):369-74. PubMed ID: 22177658
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The impact of a physician's recommendation and gender on informed decision making: A randomized controlled study in a simulated decision situation.
    Meinhardt AL; Eggeling M; Cress U; Kimmerle J; Bientzle M
    Health Expect; 2021 Apr; 24(2):269-281. PubMed ID: 33274816
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 'It's not like you just had a heart attack': decision-making about active surveillance by men with localized prostate cancer.
    Volk RJ; McFall SL; Cantor SB; Byrd TL; Le YC; Kuban DA; Mullen PD
    Psychooncology; 2014 Apr; 23(4):467-72. PubMed ID: 24243777
    [TBL] [Abstract][Full Text] [Related]  

  • 35. PCA: prostate cancer, patient-centred approach or both?
    Denis L; Joniau S; Bossi A; Baskin-Bey E; Fitzpatrick JM
    BJU Int; 2012 Jul; 110(1):16-22. PubMed ID: 22233268
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Factors influencing men undertaking active surveillance for the management of low-risk prostate cancer.
    Davison BJ; Oliffe JL; Pickles T; Mroz L
    Oncol Nurs Forum; 2009 Jan; 36(1):89-96. PubMed ID: 19136342
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Doctors' and patients' preferences for participation and treatment in curative prostate cancer radiotherapy.
    Stalmeier PF; van Tol-Geerdink JJ; van Lin EN; Schimmel E; Huizenga H; van Daal WA; Leer JW
    J Clin Oncol; 2007 Jul; 25(21):3096-100. PubMed ID: 17634489
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Describing perspectives of health care professionals on active surveillance for the management of prostate cancer.
    Pang K; Fitch M; Ouellet V; Chevalier S; Drachenberg DE; Finelli A; Lattouf JB; So A; Sutcliffe S; Tanguay S; Saad F; Mes-Masson AM
    BMC Health Serv Res; 2018 Jun; 18(1):430. PubMed ID: 29884180
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of physicians' recommendations in medical treatment decisions.
    Gurmankin AD; Baron J; Hershey JC; Ubel PA
    Med Decis Making; 2002; 22(3):262-71. PubMed ID: 12058783
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Appropriateness Criteria for Active Surveillance of Prostate Cancer.
    Cher ML; Dhir A; Auffenberg GB; Linsell S; Gao Y; Rosenberg B; Jafri SM; Klotz L; Miller DC; Ghani KR; Bernstein SJ; Montie JE; Lane BR;
    J Urol; 2017 Jan; 197(1):67-74. PubMed ID: 27422298
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.